Brunilda Shtylla, Chief Business Officer at SUTRO BIOPHARMA, INC. (STRO), sold 30,856 shares at $4.71 ($145K) on 2023-08-28, disclosed to the SEC on 2023-08-29.
Open-market sale of $145k STRO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.71 | 15,428 | $73K | 50.0% |
| 2 | $4.71 | 15,428 | $73K | 50.0% |
| Total | $4.71 avg | 30,856 | $145K | 100% |